Imexpharm Corp operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Imexpharm Corp with three other
companies in this sector in Vietnam:
Medipharco Pharmaceutical JSC
sales of 844.70 billion Dong [US$37.17 million]
Hatay Pharmaceutical JSC
(1.21 trillion Dong [US$53.04 million]
OPC Pharmaceutical JSC
(790.41 billion Dong [US$34.78 million]
During the year ended December of 2016, sales at
Imexpharm Corp were 1.01 trillion Dong (US$44.46 million).
increase of 4.8%
versus 2015, when the company's sales were 964.32 billion Dong.
This was the fifth consecutive year of sales increases at Imexpharm Corp
(and since 2011, sales have increased a total of 30%).